BRPI0607976A2 - composição farmacêutica e uso de uma composição - Google Patents
composição farmacêutica e uso de uma composiçãoInfo
- Publication number
- BRPI0607976A2 BRPI0607976A2 BRPI0607976-8A BRPI0607976A BRPI0607976A2 BR PI0607976 A2 BRPI0607976 A2 BR PI0607976A2 BR PI0607976 A BRPI0607976 A BR PI0607976A BR PI0607976 A2 BRPI0607976 A2 BR PI0607976A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- pharmaceutical composition
- pharmaceutical
- medicament
- manufacture
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000005660 Abamectin Substances 0.000 abstract 1
- 241001303601 Rosacea Species 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 201000004700 rosacea Diseases 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
COMPOSIçãO FARMACEUTICA E USO DE UMA COMPOSIçãO. A presente invenção trata de uma composição farmacêutica, em particular dermatológica, que compreende, em um meio fisiologicamente aceitável, pelo menos um composto da família das avermectinas, e o ácido azelálco, bem como de se uso para a fabricação de um medicamento destinado ao tratamento de afecções da pele, em particular da rosácea.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0502645A FR2883181B1 (fr) | 2005-03-17 | 2005-03-17 | Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee |
| PCT/FR2006/000570 WO2006097628A1 (fr) | 2005-03-17 | 2006-03-15 | Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0607976A2 true BRPI0607976A2 (pt) | 2009-10-27 |
Family
ID=35655537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0607976-8A BRPI0607976A2 (pt) | 2005-03-17 | 2006-03-15 | composição farmacêutica e uso de uma composição |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US20080139488A1 (pt) |
| EP (1) | EP1861083B1 (pt) |
| JP (1) | JP2008533112A (pt) |
| BR (1) | BRPI0607976A2 (pt) |
| CA (1) | CA2599663A1 (pt) |
| FR (1) | FR2883181B1 (pt) |
| WO (1) | WO2006097628A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2886851B1 (fr) * | 2005-06-10 | 2007-10-05 | Galderma Sa | Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee |
| FR2942138A1 (fr) * | 2009-02-16 | 2010-08-20 | Galderma Res & Dev | Association de composes pour le traitement ou la prevention des affections dermatologiques |
| US9782425B2 (en) | 2013-07-08 | 2017-10-10 | Galderma S.A. | Treatment of papulopustular rosacea with ivermectin |
| US9233117B2 (en) | 2013-07-08 | 2016-01-12 | Galderma S. A. | Treatment of inflammatory lesions of rosacea with ivermectin |
| JP6232250B2 (ja) * | 2013-10-18 | 2017-11-15 | ピアス株式会社 | 皮膚外用剤 |
| WO2015079016A1 (en) | 2013-11-29 | 2015-06-04 | Galderma Sa | Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis |
| WO2016096797A1 (en) * | 2014-12-15 | 2016-06-23 | Galderma Sa | Compound of the avermectin family in combination with an other active compound for treating and/or preventing inflammatory dermatoses |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952372A (en) * | 1998-09-17 | 1999-09-14 | Mcdaniel; William Robert | Method for treating rosacea using oral or topical ivermectin |
| US7060729B2 (en) * | 2002-09-05 | 2006-06-13 | Reza Babapour | Composition and method for treating skin |
| FR2854074B1 (fr) * | 2003-04-24 | 2007-11-23 | Galderma Res & Dev | Utilisation de l'ivermectine pour le traitement de desordres dermatologiques |
| WO2004093886A1 (en) * | 2003-04-24 | 2004-11-04 | Galderma S.A. | Topical formulation of ivermectin for the treatment of dermatological conditions |
-
2005
- 2005-03-17 FR FR0502645A patent/FR2883181B1/fr not_active Expired - Fee Related
-
2006
- 2006-03-15 JP JP2008501369A patent/JP2008533112A/ja not_active Withdrawn
- 2006-03-15 WO PCT/FR2006/000570 patent/WO2006097628A1/fr not_active Ceased
- 2006-03-15 CA CA 2599663 patent/CA2599663A1/fr not_active Abandoned
- 2006-03-15 EP EP06726096.8A patent/EP1861083B1/fr not_active Expired - Lifetime
- 2006-03-15 BR BRPI0607976-8A patent/BRPI0607976A2/pt not_active Application Discontinuation
-
2007
- 2007-09-17 US US11/898,911 patent/US20080139488A1/en not_active Abandoned
-
2010
- 2010-07-06 US US12/830,576 patent/US20110165100A1/en not_active Abandoned
-
2012
- 2012-03-01 US US13/410,234 patent/US8563524B2/en not_active Expired - Fee Related
-
2013
- 2013-09-27 US US14/040,402 patent/US9125927B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US9125927B2 (en) | 2015-09-08 |
| EP1861083A1 (fr) | 2007-12-05 |
| FR2883181A1 (fr) | 2006-09-22 |
| US20110165100A1 (en) | 2011-07-07 |
| US20130064780A1 (en) | 2013-03-14 |
| WO2006097628A1 (fr) | 2006-09-21 |
| US8563524B2 (en) | 2013-10-22 |
| US20080139488A1 (en) | 2008-06-12 |
| CA2599663A1 (fr) | 2006-09-21 |
| JP2008533112A (ja) | 2008-08-21 |
| FR2883181B1 (fr) | 2007-05-18 |
| EP1861083B1 (fr) | 2018-01-31 |
| US20140161747A1 (en) | 2014-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20070203A7 (es) | Composición farmacéutica que comprende una difenilurea sustituida con omega-carboxiarilo para el tratamiento del cáncer | |
| MXPA05011208A (es) | Uso de ivermectina para el tratamiento de desordenes dermatologicos. | |
| BR112013000537A2 (pt) | composição aquosa contendo bromexina | |
| EA201300121A1 (ru) | Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения | |
| BRPI0815708B8 (pt) | composto, éster de pró-droga, composição farmacêutica, e, método para tratar uma doença ou condição | |
| PE20050255A1 (es) | Nuevas cianotiazolidas y procedimiento para su preparacion como medicamentos | |
| BR0308928A (pt) | Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular | |
| BRPI0912411A2 (pt) | uso de uma muteína de interleucina humana-2 (muteína de hil-2) ou de um fragmento da mesma, composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune, uso de muteína de interleucina humana-2 (muteína de hil-2) ou de uma seção da mesma, agete para formação de células t regulatórias (treg) em um organismo, método para tratamento e/ou profilaxia de uma doença autoimune em um organismo, método para formação de células t regulatórias (treg) em um organismo, método para formação de células t regulatórias (treg) in vitro. | |
| CO6351803A2 (es) | Anticuerpos monoclonales contra el inhibidor de la via del factor tisular (tfpi) | |
| BRPI0812638A2 (pt) | "método para diminuir a pressão em um indivíduo método para reduzir inflamação vascular em um indivíduo, composição farmacêutica para diminuira pressão sanguínea em um indivíduo e uso de uma composição" | |
| BRPI0925036B8 (pt) | uso de trans-t-butil ciclo-hexanol, composição cosmética, medicamento, seus usos e processos para tratar irritação na pele | |
| CR9949A (es) | Inhibidores de proteina activadora de la 5-lipoxigenasa (flap) | |
| EA021275B9 (ru) | Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение для лечения pask-опосредованного заболевания | |
| BRPI0923589A2 (pt) | uso de uma composição espumável essencialmente livre de ingredientes farmaceuticamente ativos para o tratamento da pele humana. | |
| EA201300522A1 (ru) | Фармацевтические комбинации для лечения метаболических нарушений | |
| CL2008000593A1 (es) | Uso de compuestos derivados de heterociclos sustituidos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad aterosclerotica de las arterias entre otras enfermedades. | |
| WO2009040420A3 (en) | Use of a monoterpene to increase tissue repair | |
| EA201001287A1 (ru) | Лечение гиперглицемии 25-гидроксивитамином d3 | |
| UY30215A1 (es) | Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones | |
| AR049518A1 (es) | Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados | |
| BRPI0415215B8 (pt) | uso de polifenol na preparação de medicamento | |
| ECSP10010464A (es) | Uso de ranolazina para el tratamiento de enfermedades cardiovasculares | |
| BRPI0607976A2 (pt) | composição farmacêutica e uso de uma composição | |
| GT200600109A (es) | Derivados de acido pirimidincarboxilico y su uso | |
| AR079000A1 (es) | Terapia anticancerosa dirigida a celulas madre cancerosas resistentes a las drogas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |